A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Vaxart, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 924,300 shares of VXRT stock, worth $628,524. This represents 0.0% of its overall portfolio holdings.

Number of Shares
924,300
Previous 42,500 2074.82%
Holding current value
$628,524
Previous $24,000 4908.33%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$0.56 - $1.41 $493,808 - $1.24 Million
881,800 Added 2074.82%
924,300 $1.2 Million
Q4 2023

Feb 13, 2024

BUY
$0.57 - $0.85 $4,446 - $6,630
7,800 Added 22.48%
42,500 $24,000
Q3 2023

Nov 14, 2023

SELL
$0.69 - $0.85 $522,540 - $643,709
-757,305 Reduced 95.62%
34,700 $26,000
Q2 2023

Aug 11, 2023

BUY
$0.6 - $1.41 $441,328 - $1.04 Million
735,548 Added 1302.85%
792,005 $578,000
Q1 2023

May 12, 2023

SELL
$0.71 - $1.25 $678,304 - $1.19 Million
-955,359 Reduced 94.42%
56,457 $43,000
Q4 2022

Feb 13, 2023

BUY
$0.75 - $2.24 $758,862 - $2.27 Million
1,011,816 New
1,011,816 $972,000
Q3 2020

Nov 13, 2020

SELL
$4.78 - $16.97 $2.95 Million - $10.5 Million
-616,328 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$1.68 - $8.85 $2.62 Million - $13.8 Million
-1,557,400 Reduced 71.65%
616,328 $5.46 Million
Q1 2020

May 14, 2020

BUY
$0.34 - $2.87 $273,344 - $2.31 Million
803,954 Added 58.69%
2,173,728 $3.85 Million
Q4 2019

Feb 13, 2020

BUY
$0.28 - $0.39 $113,069 - $157,490
403,821 Added 41.81%
1,369,774 $480,000
Q3 2019

Nov 13, 2019

BUY
$0.3 - $0.75 $67,890 - $169,725
226,300 Added 30.6%
965,953 $347,000
Q2 2019

Aug 12, 2019

BUY
$0.63 - $2.04 $255,076 - $825,961
404,883 Added 120.94%
739,653 $496,000
Q1 2019

May 14, 2019

BUY
$1.5 - $2.34 $95,412 - $148,842
63,608 Added 23.46%
334,770 $649,000
Q4 2018

Feb 13, 2019

BUY
$1.88 - $5.25 $509,784 - $1.42 Million
271,162 New
271,162 $510,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $86M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.